Literature DB >> 22343147

Status epilepticus: a review, with emphasis on refractory cases.

Gary Hunter1, G Bryan Young.   

Abstract

Status epilepticus is among the most dramatic of clinical presentations encountered by emergency room physicians, neurologists, neurosurgeons and intensivists. While progress in its management has been aided significantly with an increasing number of effective treatment options, improved diagnostic methods and more effective monitoring, poor outcomes and diagnostic failures are still frequently encountered. Refractory cases still carry significant morbidity and mortality rates, including poor cognitive outcomes. This review discusses basic pathophysiology and management of status epilepticus, neuroimaging findings, the role of continuous electroencephalogram monitoring and nonconvulsive status epilepticusas well as recent developments in treatment options for refractory cases.

Entities:  

Mesh:

Year:  2012        PMID: 22343147     DOI: 10.1017/s0317167100013160

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

Review 1.  Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures.

Authors:  Patrick L Purdon; Aaron Sampson; Kara J Pavone; Emery N Brown
Journal:  Anesthesiology       Date:  2015-10       Impact factor: 7.892

2.  Electroclinical progression of subtle generalized convulsive status epilepticus: description of a case.

Authors:  José L Fernández-Torre; Eloy Rodríguez-Rodríguez; José L Vázquez-Higuera; Miguel A Hernández-Hernández
Journal:  J Neurol       Date:  2013-10-23       Impact factor: 4.849

3.  Nitrous oxide-induced slow and delta oscillations.

Authors:  Kara J Pavone; Oluwaseun Akeju; Aaron L Sampson; Kelly Ling; Patrick L Purdon; Emery N Brown
Journal:  Clin Neurophysiol       Date:  2015-06-10       Impact factor: 3.708

Review 4.  NMDA antagonists for refractory seizures.

Authors:  F A Zeiler; J Teitelbaum; L M Gillman; M West
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

5.  A brain-machine interface for control of medically-induced coma.

Authors:  Maryam M Shanechi; Jessica J Chemali; Max Liberman; Ken Solt; Emery N Brown
Journal:  PLoS Comput Biol       Date:  2013-10-31       Impact factor: 4.475

Review 6.  Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus.

Authors:  F A Zeiler
Journal:  Crit Care Res Pract       Date:  2015-01-12

7.  Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model.

Authors:  Asheebo Rojas; Wenyi Wang; Avery Glover; Zahra Manji; Yujiao Fu; Raymond Dingledine
Journal:  eNeuro       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.